Veritas In Silico Inc.

130A・Growth Market・Pharmaceuticals

Official website

Veritas In Silico Inc.

130A・Growth Market・Pharmaceuticals

Official website

Veritas In Silico Inc.130A

Reference Indicators

Market Cap

26¥100M

P/E (Forecast)

—

P/B

1.5x

Dividend Yield (Forecast)

0.00%

ROE

-23.9%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	360	194	91
SG&A Expenses	186	235	272
Operating Income	37	-212	-396
Non-operating Income	0	1	6
Non-operating Expenses	2	22	—
Ordinary Income	35	-233	-390
Extraordinary Losses	—	—	31
Pre-tax Income	35	-233	-421
Income Taxes	2	2	3
Net Income	33	-236	-425
EBITDA	64	-197	-380
Operating Margin	10.4%	-109.4%	-435.3%
ROA	2.0%	-10.5%	-22.6%
ROE	2.1%	-10.7%	-23.9%